Inventor · disambiguated record
Robin Frey
Also filed as: FREY ROBIN · FREY ROBIN R
20 granted patents·35 pending applications·65 citations·filing 2001–2025
93Inventor score
Top patents by PatentIndex Score
55 records- 0192US8940737B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2012·Granted Jan 27, 2015·7 cites·10 claims
- 0290US8975398B2NAMPT inhibitorsABBVIE INC·Filed 2013·Granted Mar 10, 2015·13 cites·13 claims
- 0388US8889675B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2012·Granted Nov 18, 2014·3 cites·9 claims
- 0487US2024285611A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2023·Application pending·0 cites
- 0586US9266877B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2014·Granted Feb 23, 2016·2 cites·2 claims
- 0686US9227963B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2014·Granted Jan 5, 2016·2 cites·2 claims
- 0784US2025177374A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2024·Application pending·0 cites
- 0883US9187472B2NAMPT inhibitorsABBVIE INC·Filed 2013·Granted Nov 17, 2015·5 cites·1 claims
- 0982US7202363B2Thienopyridine and furopyridine kinase inhibitorsABBOTT LAB·Filed 2004·Granted Apr 10, 2007·12 cites·9 claims
- 1077US9877958B2Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2016·Granted Jan 30, 2018·1 cites·16 claims
- 1177US9844547B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2015·Granted Dec 19, 2017·1 cites·10 claims
- 1277US2024058450A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2022·Application pending·0 cites
- 1376US9193723B2NAMPT inhibitorsABBVIE INC·Filed 2013·Granted Nov 24, 2015·2 cites·18 claims
- 1476US8426408B2Pyrimidine inhibitors of kinasesCURTIN MICHAEL·Filed 2010·Granted Apr 23, 2013·7 cites·14 claims
- 1574US11786519B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2020·Granted Oct 17, 2023·0 cites·5 claims
- 1674US2024199745A1Anti-egfr antibody drug conjugatesABBVIE INC·Filed 2023·Application pending·0 cites
- 1774US2021346369A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2020·Application pending·0 cites
- 1873US9994581B2Bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Jun 12, 2018·2 cites·22 claims
- 1973US2020345717A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2019·Application pending·0 cites
- 2073US2020253954A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2019·Application pending·0 cites
- 2173US2020246460A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2019·Application pending·0 cites
- 2270US7737160B2Thienopyridine and furopyridine kinase inhibitorsABBOTT LAB·Filed 2007·Granted Jun 15, 2010·2 cites·16 claims
- 2370US2018140595A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2017·Application pending·0 cites
- 2470US2018221363A1Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2017·Application pending·0 cites
- 2569US8273736B2Thienopyridine and furopyridine kinase inhibitorsBETSCHMANN PATRICK·Filed 2009·Granted Sep 25, 2012·1 cites·14 claims
- 2669US7560552B2Thiopyrimidine and isothiazolopyrimidine kinase inhibitorsABBOTT LAB·Filed 2003·Granted Jul 14, 2009·3 cites·2 claims
- 2769US2010076051A1Isoindolinone kinase inhibitorsABBOTT LAB·Filed 2009·Application pending·0 cites
- 2868US8722890B2Thieno[3,2-C]pyridine kinase inhibitors with improved CYP safety profileMICHAELIDES MICHAEL R·Filed 2012·Granted May 13, 2014·1 cites·7 claims
- 2964US2020239553A1BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2019·Application pending·0 cites
- 3062US2019142941A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2019·Application pending·0 cites
- 3161US7129260B2Isoindolinone kinase inhibitorsABBOTT LAB·Filed 2004·Granted Oct 31, 2006·1 cites·15 claims
- 3254US2018193315A1Spirocyclic hat inhibitors and methods for their useABBVIE INC·Filed 2018·Application pending·0 cites
- 3353US2016339117A1BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the SameABBVIE INC·Filed 2015·Application pending·0 cites
- 3453US2018071262A1Spirocyclic hat inhibitors and methods for their useABBVIE INC·Filed 2017·Application pending·0 cites
- 3552US2016184281A1Nampt inhibitorsABBVIE INC·Filed 2015·Application pending·0 cites
- 3652US2017065575A1Nampt inhibitorsABBVIE INC·Filed 2016·Application pending·0 cites
- 3752US2017135994A9Nampt inhibitorsABBVIE INC·Filed 2015·Application pending·0 cites
- 3851US2025333394A1Tiparp Inhibitor CompoundsABBVIE INC·Filed 2025·Application pending·0 cites
- 3951US2006287370A1Isoindolinone kinase inhibitorsCURTIN MICHAEL L·Filed 2006·Application pending·0 cites
- 4051US2006276490A1Thiopyrimidine and isothiazolopyrimidine Kinase InhibitorsMICHAELIDES MICHAEL R·Filed 2006·Application pending·0 cites
- 4149US9328112B2Tetracyclic CDK9 kinase inhibitorsABBVIE INC·Filed 2014·Granted May 3, 2016·0 cites·9 claims
- 4248US2019153107A1Anti-egfr antibody drug conjugatesABBVIE INC·Filed 2017·Application pending·0 cites
- 4347US2007135387A1Inhibitors of protein kinasesMICHAELIDES MICHAEL R·Filed 2006·Application pending·0 cites
- 4447US2015141398A1Nampt inhibitorsABBVIE INC·Filed 2015·Application pending·0 cites
- 4547US2016235716A1Spirocyclic hat inhibitors and methods for their useABBVIE INC·Filed 2015·Application pending·0 cites
- 4644US2005026944A1Thienopyridine and furopyridine kinase inhibitorsFiled 2004·Application pending·0 cites
- 4743US2020002432A1Anti-cd98 antibodies and antibody drug conjugatesABBVIE INC·Filed 2017·Application pending·0 cites
- 4843US2003225273A1Thiopyrimidine and isothiazolopyrimidine kinase inhibitorsFiled 2003·Application pending·0 cites
- 4942US2016158377A1BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the SameACKLER SCOTT L·Filed 2015·Application pending·0 cites
- 5041US2005020619A1Thienopyridine kinase inhibitorsFiled 2003·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →